tiprankstipranks
Sumitomo Dainippon Pharma Co Ltd (JP:4506)
:4506
Japanese Market
4506
Sumitomo Dainippon Pharma Co
RESEARCH TOOLSreports
Want to see JP:4506 full AI Analyst Report?

Sumitomo Dainippon Pharma Co (4506) Income Statement

7 Followers

Sumitomo Dainippon Pharma Co Income Statement

Last quarter (Q4 2025), Sumitomo Dainippon Pharma Co's total revenue was ¥105.65B, an increase of 17.29% from the same quarter last year. In Q4, Sumitomo Dainippon Pharma Co's net income was ¥2.42B. See Sumitomo Dainippon Pharma Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 26Mar 25Mar 24Mar 23
Total Revenue
¥ 398.83B¥ 453.29B¥ 314.56B¥ 555.54B¥ 560.03B
Gross Profit
¥ 225.38B¥ 256.89B¥ 157.08B¥ 342.95B¥ 371.18B
Operating Expenses
¥ 202.96B¥ 206.55B¥ 158.55B¥ 331.74B¥ 314.62B
Depreciation and Amortization
¥ 25.56B¥ 20.79B¥ 37.77B¥ 41.26B¥ 38.35B
EBITDA
¥ 47.98B¥ 71.13B¥ 36.29B¥ 52.47B¥ 94.90B
Operating Income
¥ 22.42B¥ 50.34B¥ -1.48B¥ 11.20B¥ 56.55B
Other Income/Expenses
¥ -4.81B¥ 50.00B¥ -321.64B¥ -59.12B¥ 26.41B
Pretax Income
¥ 17.61B¥ 100.34B¥ -323.11B¥ -47.92B¥ 82.96B
Net Income
¥ 23.63B¥ 106.86B¥ -314.97B¥ -74.51B¥ 56.41B
Per Share Metrics
Basic EPS
¥ 59.49¥ 268.99¥ -792.79¥ -187.55¥ 141.99
Diluted EPS
¥ 59.49¥ 268.99¥ -792.79¥ -187.55¥ 141.99
Weighted Average Shares Outstanding
 397.29M 397.29M 397.29M 397.29M 397.29M
Weighted Average Shares Outstanding (Diluted)
 397.29M 397.29M 397.29M 397.29M 397.29M
Currency in JPY

Sumitomo Dainippon Pharma Co Earnings and Revenue History